Varicocele is the most common reversible cause of male infertility, affecting up to 20% of healthy men and 40% of men with primary infertility. The objective of this study was to investigate the prevalence of varicocele in men evaluated for infertility, and to determine rates of subsequent varicocele repair. Since reproductive endocrinologists are the first specialists seen for male infertility care in North America, we hypothesized that varicocele would be underdiagnosed when compared to its reported prevalence among men with infertility. TriNetX, a large, multicenter electronic health record (EHR) database was queried to establish a cohort of all men (above 18 years of age) with a diagnosis of male infertility. This cohort was used to identify those with ensuing varicocele diagnosis. Men who received varicocelectomy or venous embolization after a diagnosis of varicocele were then identified. Out of 101,309 men with a diagnosis of male infertility in the network, only 9768 (9.6%) had a diagnosis of varicocele. Mean age of men with varicocele was 34. Varicocelectomy or venous embolization was performed in 1699 (20.2%) and 69 (0.76%) of men with varicocele, respectively. In this cross‐sectional EHR study, varicocele was underdiagnosed in men evaluated for infertility when compared with prior epidemiological studies.

Although mRNA COVID‐19 vaccines have proven to be safe and effective against SARS‐CoV‐2, vaccination rates have slowed, with some individuals citing impotence as a concern. Therefore, we conducted a survey of the US males to evaluate the impact of COVID‐19 vaccination on erectile function. We hypothesized that vaccinated men would not have a higher risk of ED compared to unvaccinated men. Amazon Mechanical Turk (MTurk) was utilized to survey the US adult male population between August 26 and September 2, 2021. Survey participation was open to 1000 males over the age of 18 and currently living in the United States regardless of vaccination status or the past medical history of COVID‐19. Selection criteria included respondents ≥45 years old, no history of physician‐diagnosed ED, biologically born, and identify as male. Participants completed an anonymous 16‐question survey that included a multidimensional scale used to evaluate ED, the International Index of Erectile Function (IIEF‐5). Among vaccinated men, the median IIEF‐5 score was 20 [16–24] compared to 22 [17.5–25] in the unvaccinated group (p = 0.195). The multivariable‐adjusted analysis demonstrated that vaccination against COVID‐19 was not associated with increased risk of ED. Overall, this cross‐sectional survey showed that COVID‐19 vaccination was not associated with an increased risk of erectile dysfunction in males 45 years and older.

No abstract